A breakthrough in understanding the biology and treatment of ovarian cancer

Researchers at the Pennsylvania State University College of Medicine, Hershey, Pa., have discovered that the presence and integrity of the opioid growth factor receptor (OGFr), which mediates the inhibitory action of opioid growth factor (OGF) on cell proliferation, is a key to understanding the progression and treatment of human ovarian cancer. Read more